Q5099 Injection ustekinumab-stba, 1 milligrams
Also known as: Krazeolaug injection, ustekinumab-stba
Injection of ustekinumab-stba (Krazeolaug) biosimilar per 1 milligram, for inflammatory condition management.
In Plain Language
anti-inflammatory biologic injection; immune regulator
Clinical Context
Indicated for psoriasis, plaque psoriasis, and inflammatory bowel disease treatment.
RVU Information
CPT Q5099 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5099?
CPT Q5099 (Injection ustekinumab-stba, 1 milligrams) is a Q Codes code. Injection of ustekinumab-stba (Krazeolaug) biosimilar per 1 milligram, for inflammatory condition management.
Is Q5099 covered by insurance?
Q5099 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Indicated for psoriasis, plaque psoriasis, and inflammatory bowel disease treatment.
When is CPT Q5099 used?
Indicated for psoriasis, plaque psoriasis, and inflammatory bowel disease treatment.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.